Ophthalmology Doctors in Jbsa Lackland, TX Accepting Medicare

8 Ophthalmology doctors found. Showing 1 - 8

Paramjit Bhullar, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-916-9900

Jared Christopher Kelstrom, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-6030

Miriam Friedman, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop, Bldg 4554, Ophthalmology Clinic, Jbsa Lackland, TX 78236 Phone: 210-292-6030

Brett W. Davies, MD Ophthalmology - Ophthalmic Plastic and Reconstructive Surgery Medicare: Accepting Medicare Assignments Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-6225

Dr. Samuel David Hobbs, M.D. Ophthalmology - Retina Specialist Medicare: Accepting Medicare Assignments Practice Location: 1100 Wilford Hall Loop, Jbsa Lackland, TX 78236 Phone: 210-292-6030

Dr. Zachary Heath, M.D. Ophthalmology Medicare: Medicare Enrolled Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-4277

Dr. Timothy Adam Soeken, MD Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-6030

Andrew Wayne Lewis, MD Ophthalmology - Glaucoma Specialist Medicare: Not Enrolled in Medicare Practice Location: 1100 Wilford Hall Loop Bldg 4554, Jbsa Lackland, TX 78236 Phone: 210-292-6583

News Archive

Genevac offers miVac DNA for efficient concentration of nucleic acids

miVac DNA centrifugal sample concentrator efficiently removes water and organic solvents from biological samples containing nucleic acids.

NIH provides Inviragen second major grant to develop a dengue vaccine

Inviragen has received a $600,000 grant from the National Institute of Allergy and Infectious Diseases, part of the National Institutes of Health, to partially support its continued efforts to develop a safe and effective dengue vaccine. The two-year grant will fund a collaborative effort led by Inviragen and involving scientists at the University of Wisconsin and Division of Vector-Borne Infectious Diseases at the Centers for Disease Control and Prevention (CDC). The supported work will include additional optimization of Inviragen's vaccine to generate more potent immune responses.

Life Technologies takes orders for new benchtop Ion Proton Sequencer

Life Technologies Corporation today announced it is taking orders for the new benchtop Ion Proton Sequencer that is designed to sequence the entire human genome in a day for $1,000.

KAIST research team finds cause of sepsis-induced lung injury

A KAIST research team succeeded in visualizing pulmonary microcirculation and circulating cells in vivo with a custom-built 3D intravital lung microscopic imaging system.

Read more Medical News

› Verified 2 days ago